// App-Quantinova.ai

: Assisted Reproductive Technology Required to Achieve High Conception Rates, Despite a Low Incidence of Hypogonadotrophic Hypogonadism in Thalassemia and Sickle Cell Disease Patients

Researchers

Presenter

  • Jacinta Perram

Principal Investigators

  • Stephanie Anderson

  • Stephen Matthews

  • Melly Gou

  • P. Joy Ho

Medical Centers

  • Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Sickle cell anemia

  • Thalassemia

Biomarkers

  • Stearoyl-CoA desaturase

  • Tumor doubling time

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved